PL3897595T3 - Oftalmiczna kompozycja nutraceutyczna do leczenia schorzeń siatkówki z komponentą neowaskularną - Google Patents
Oftalmiczna kompozycja nutraceutyczna do leczenia schorzeń siatkówki z komponentą neowaskularnąInfo
- Publication number
- PL3897595T3 PL3897595T3 PL19829158.5T PL19829158T PL3897595T3 PL 3897595 T3 PL3897595 T3 PL 3897595T3 PL 19829158 T PL19829158 T PL 19829158T PL 3897595 T3 PL3897595 T3 PL 3897595T3
- Authority
- PL
- Poland
- Prior art keywords
- ophthalmic
- treatment
- retinal disease
- nutraceutical composition
- neovascular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306772 | 2018-12-20 | ||
| PCT/EP2019/086174 WO2020127641A1 (fr) | 2018-12-20 | 2019-12-19 | Composition ophtalmique nutraceutique pour le traitement de pathologies retiniennes a composante neovasculaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3897595T3 true PL3897595T3 (pl) | 2023-05-08 |
Family
ID=65200511
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19829158.5T PL3897595T3 (pl) | 2018-12-20 | 2019-12-19 | Oftalmiczna kompozycja nutraceutyczna do leczenia schorzeń siatkówki z komponentą neowaskularną |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20240374634A1 (pl) |
| EP (1) | EP3897595B1 (pl) |
| CA (1) | CA3122227A1 (pl) |
| DK (1) | DK3897595T3 (pl) |
| ES (1) | ES2940767T3 (pl) |
| FI (1) | FI3897595T3 (pl) |
| HR (1) | HRP20230283T1 (pl) |
| HU (1) | HUE061286T2 (pl) |
| LT (1) | LT3897595T (pl) |
| MA (1) | MA54511B1 (pl) |
| PL (1) | PL3897595T3 (pl) |
| PT (1) | PT3897595T (pl) |
| RS (1) | RS64066B1 (pl) |
| SI (1) | SI3897595T1 (pl) |
| SM (1) | SMT202300093T1 (pl) |
| UA (1) | UA127874C2 (pl) |
| WO (1) | WO2020127641A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210021299A (ko) | 2018-05-10 | 2021-02-25 | 리제너론 파아마슈티컬스, 인크. | 고농도 vegf 수용체 융합 단백질 함유 제제 |
| CN120695200A (zh) * | 2025-07-18 | 2025-09-26 | 四川省医学科学院·四川省人民医院 | 四面体框架核酸-白藜芦醇复合物在制备治疗视网膜新生血管性疾病的药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3034018B1 (fr) | 2015-03-25 | 2017-11-03 | Thea Lab | Composition ophtalmique nutraceutique pour la sante oculaire |
| JP2019501200A (ja) * | 2016-01-08 | 2019-01-17 | クリアサイド バイオメディカル，インコーポレイテッド | 後眼部障害をアフリベルセプトおよびその他の生物製剤で処置するための方法およびデバイス |
-
2019
- 2019-12-19 HR HRP20230283TT patent/HRP20230283T1/hr unknown
- 2019-12-19 US US17/309,695 patent/US20240374634A1/en active Pending
- 2019-12-19 LT LTEPPCT/EP2019/086174T patent/LT3897595T/lt unknown
- 2019-12-19 CA CA3122227A patent/CA3122227A1/fr active Pending
- 2019-12-19 MA MA54511A patent/MA54511B1/fr unknown
- 2019-12-19 HU HUE19829158A patent/HUE061286T2/hu unknown
- 2019-12-19 DK DK19829158.5T patent/DK3897595T3/da active
- 2019-12-19 UA UAA202103400A patent/UA127874C2/uk unknown
- 2019-12-19 FI FIEP19829158.5T patent/FI3897595T3/en active
- 2019-12-19 PL PL19829158.5T patent/PL3897595T3/pl unknown
- 2019-12-19 PT PT198291585T patent/PT3897595T/pt unknown
- 2019-12-19 SM SM20230093T patent/SMT202300093T1/it unknown
- 2019-12-19 ES ES19829158T patent/ES2940767T3/es active Active
- 2019-12-19 RS RS20230215A patent/RS64066B1/sr unknown
- 2019-12-19 SI SI201930498T patent/SI3897595T1/sl unknown
- 2019-12-19 WO PCT/EP2019/086174 patent/WO2020127641A1/fr not_active Ceased
- 2019-12-19 EP EP19829158.5A patent/EP3897595B1/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE061286T2 (hu) | 2023-06-28 |
| LT3897595T (lt) | 2023-04-25 |
| EP3897595B1 (fr) | 2023-03-15 |
| HRP20230283T1 (hr) | 2023-05-12 |
| MA54511B1 (fr) | 2023-04-28 |
| CA3122227A1 (fr) | 2020-06-25 |
| ES2940767T3 (es) | 2023-05-11 |
| SMT202300093T1 (it) | 2023-05-12 |
| SI3897595T1 (sl) | 2023-04-28 |
| DK3897595T3 (da) | 2023-03-27 |
| EP3897595A1 (fr) | 2021-10-27 |
| PT3897595T (pt) | 2023-03-22 |
| WO2020127641A1 (fr) | 2020-06-25 |
| FI3897595T3 (en) | 2023-03-31 |
| MA54511A (fr) | 2022-03-30 |
| US20240374634A1 (en) | 2024-11-14 |
| RS64066B1 (sr) | 2023-04-28 |
| UA127874C2 (uk) | 2024-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018008557A (es) | Anticuerpos peptidicos beta amiloide anti-n3pglu y usos de los mismos. | |
| IL281773A (en) | Ophthalmic composition for treatment of dry eye disease | |
| LT3864003T (lt) | Integruoto streso mechanizmo provaistų moduliatoriai | |
| PL3600309T3 (pl) | Skojarzenia terapeutyczne do leczenia chorób wątroby | |
| IL268850A (en) | Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases | |
| LT3416631T (lt) | Terapiniai agentai, skirti neurodegeneracinių ligų gydymui | |
| PT3481846T (pt) | 24-hidroxiesteroides 11-substituídos para utilização no tratamento de afeções relacionadas com nmda | |
| CO2017000346A2 (es) | Anticuerpos de unión a protofibrillas aβ | |
| BR112016027136A2 (pt) | Válvula protética para tratamento de doenças que causam refluxo afetando os membros inferiores | |
| IL284344A (en) | Pharmaceutical preparations for the eyes and methods for the treatment of diseases of the surface of the eye | |
| IL272601A (en) | Pharmaceutical compositions for the treatment of ophthalmic conditions | |
| SG11202011018PA (en) | 1,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization | |
| SG11202011010YA (en) | 1,3-thiazol-2-yl substituted benzamides for the treatment of diseases associated with nerve fiber sensitization | |
| HUE058921T2 (hu) | Bisz-kolin-tetratiomolibdát wilson-betegség kezelésére | |
| MA46621A (fr) | Traitements combinés comprenant l'administration d'imidazopyrazinones | |
| IL281244A (en) | Combination therapy for the treatment of liver disease | |
| IL278889B2 (en) | Dosage regimen for the treatment of PI3K-related disorders | |
| DK3419672T5 (da) | Genterapi til behandling af retinal degenerationssygdom | |
| PL3897595T3 (pl) | Oftalmiczna kompozycja nutraceutyczna do leczenia schorzeń siatkówki z komponentą neowaskularną | |
| HUE069280T2 (hu) | Ebselen a Meniere-kór kezelésére történõ felhasználásra | |
| IL259381B (en) | Mirabegron for the treatment of retinal diseases | |
| PL3515409T3 (pl) | Kompleks i kompozycje do leczenia chorób okulistycznych i dermatologicznych | |
| DK3519050T3 (da) | Sammensætninger til behandling af oftalmiske sygdomme | |
| IL251024A0 (en) | Antibodies against eutaxin 2 for use in the treatment of liver diseases | |
| EP4048201A4 (en) | Retinal prostheses |